Industry anticipates policy reversal for embryonic stem cells

11/10/2008 | Washington Post, The

Scientists and companies working on treatments based on stem cells are looking forward to President-elect Barack Obama's plan to repeal a directive restricting the use of federal funds for embryonic stem cell research. The move could boost interest and investment in firms such as Advanced Cell Technology, which has been struggling to obtain financing for research.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA